NHE3 intestinal sodium
Selected indexed studies
- Intestinal Permeability, Irritable Bowel Syndrome with Constipation, and the Role of Sodium-Hydrogen Exchanger Isoform 3 (NHE3). (Clin Exp Gastroenterol, 2024) [PMID:38860153]
- An inducible intestinal epithelial cell-specific NHE3 knockout mouse model mimicking congenital sodium diarrhea. (Clin Sci (Lond), 2020) [PMID:32227118]
- Novel Treatments from Inhibition of the Intestinal Sodium-Hydrogen Exchanger 3. (Int J Nephrol Renovasc Dis, 2021) [PMID:34880650]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Intestinal Permeability, Irritable Bowel Syndrome with Constipation, and the Role of Sodium-Hydrogen Exchanger Isoform 3 (NHE3). (2024) pubmed
- An inducible intestinal epithelial cell-specific NHE3 knockout mouse model mimicking congenital sodium diarrhea. (2020) pubmed
- Novel Treatments from Inhibition of the Intestinal Sodium-Hydrogen Exchanger 3. (2021) pubmed
- Enhanced phosphate absorption in intestinal epithelial cell-specific NHE3 knockout mice. (2022) pubmed
- Pharmacologic inhibition of intestinal sodium uptake: a gut centric approach to sodium management. (2015) pubmed
- The epithelial sodium/proton exchanger, NHE3, is necessary for renal and intestinal calcium (re)absorption. (2012) pubmed
- NHE3 regulatory complexes. (2009) pubmed
- Hyperphosphatemia in Kidney Failure: Pathophysiology, Challenges, and Critical Role of Phosphorus Management. (2025) pubmed
- Reduced sodium/proton exchanger NHE3 activity causes congenital sodium diarrhea. (2015) pubmed
- New functions and roles of the Na(+)-H(+)-exchanger NHE3. (2024) pubmed